NVO : Analysis & Opinions

  1. Vanguard Launches 2 Dividend-Oriented International ETFs (VIGI, ...

    May 2, 2016
    Find out about two international dividend ETFs launched by Vanguard in March 2016, patterned after its Dividend Appreciation ...
  2. Analyzing Gilead's Return on Equity (GILD, NVO)

    March 7, 2016
    Explore Gilead Science's 2015 return on equity (ROE). Learn about the impact of net margin, asset turnover and financial ...
  3. Novo Nordisk: The Drug Firm You've Yet to Hear Of

    March 7, 2016
    Novo Nordisk, a Danish drugmaker, makes billions primarily by fighting hemophilia and diabetes. Here's its story.
  4. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

    December 22, 2015
    Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational ...
  5. Why Biotech Affimed N.V. Should Be On Your Radar (JUNO, AFMD)

    December 8, 2015
    In the world of developmental biotech, picking the correct early stage companies can potentially make investors a fortune.
  6. Like Ranges? These Are Stocks to Consider

    November 20, 2015
    Whether you want to trade the price fluctuations within a range, or await a breakout, here are four stocks for you.
  7. Is This Diabetes Stock a Better Bet Than MannKind? (MNKD, NVO)

    May 27, 2015
    MannKind's (NASDAQ: MNKD) inhaled insulin, Afrezza, is incredibly intriguing, but Novo Nordisk's (NYSE: NVO) long-standing ...
  8. Four Key Pharmaceuticals ETFs To Consider

    March 25, 2015
    ETF funds are now very liquid investments and are suitable to investors who seek to match the price performance of the indexes ...
  9. Novo Nordisk Getting Its Trial By Fire

    August 8, 2013
    Novo Nordisk is facing more challenges than it has in a while, but the growth remains strong.
  10. Taking The Contrarian Approach With European Equities

    July 2, 2013
    Investors continue to shun European equities due to the regions debt issues and economic problems. However, that’s a real ...
  11. Investing For The Global Diabetes Epidemic

    May 31, 2013
    Sadly, diabetes is quickly becoming a global epidemic. Within these grim statistics, investors can find opportunities with ...
  12. Novo Nordisk Still One Of The Best Around

    May 3, 2011
    Novo Nordisk is one of the best pharmaceutical companies in the world - and it's priced accordingly.
  13. Investing For The Diabetes Epidemic

    July 30, 2010
    Sadly, diabetes is quickly becoming a global epidemic. Nearly 300 million people suffer from the disease worldwide.
  14. Investing In Scandinavia

    April 29, 2010
    The Scandinavian region is often overlooked from an investment perspective, but it shouldn't be.
Trading Center